Demographics of the study population
| Cohort Features | n = 88 (%, or range) |
|---|---|
| Female (%) | 52 (59) |
| Avg. age (range) (yr) | 48.5 (22–78) |
| White (%) | 70 (80) |
| Polyps (%) | 59 (67) |
| Asthma (%) | 53 (60) |
| AERD (%) | 8 (9) |
| Never smoker (%) | 55 (62) |
| Prior surgery (%) | 48 (55) |
| Avg. absolute serum eosinophils × 109/L | 0.31 (0–2.6) |
| Avg. tissue eosinophils per HPF | 80 (0–413) |
| Avg. SNOT-22 | 49.6 (15–95) |
| Avg. LKS | 6.8 (1–12) |
| Avg. LMS | 13.5 (2–24) |
| Avg. GOSS | 2.7 (0–35) |
| Avg. sinus cavity volume (mL) | 60.8 (24.8–109.0) |
| Avg. %SO | 60.1 (20.7–99.6) |
| Avg. mHU | 10.5 (−139.2 to +57.4) |
| Avg. %OST | 41.4 (32.1–52.2) |
Note:—AERD indicates aspirin-exacerbated respiratory disease; HPF, high-power field; Avg., average.